Manal Morsy 

Biography

Dr. Morsy joined Athersys in 2013 as Vice President and Head of Global Regulatory Affairs and has served as our Senior Vice President and Head of Global Regulatory Affairs since September 2016.  She is responsible for the global regulatory activities for the Company’s therapeutic programs, including its MultiStem® cell therapy.  

Research Interest

Prior to joining Athersys, Dr. Morsy served as Vice President at PTC Therapeutics, Inc. since 2007 where she led global regulatory affairs, developed the company’s regulatory capabilities and was responsible for regulatory activities for multiple programs in several therapeutic areas, including the programs for treatment of Duchene muscular dystrophy and cystic fibrosis using Ataluren, the company’s lead product candidate.  Prior to joining PTC, Dr. Morsy spent three years at Tibotec / J&J, serving as Senior Director, Global Regulatory Affairs, where she was responsible for global regulatory activities for the company’s pediatric development programs, the tuberculosis and the HIV (Prezista) programs.